(S)-1,1,1-Trifluoro-4-methyl-2-pentylamine, 95.0%, 1g

4-tert-butyl-N-(3-formylphenyl)benzenesulfonamide, 1g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 50 m, Ø-Innen 0,20 mm, Filmd. 0,50 µm, 1 Stück

FMOC-(R)-3-AMINO-4,4-DIPHENYL-BUTYRIC ACID, 98%, 250mg

5-Fluoro-1h,2h,3h-pyrrolo[2,3-b]pyridine, 97%, 100mg

2-CHLORO-4-FLUORO-5-IODOPYRIDINE, 95.0%, 1g

2-Chloro-4-(5-fluoro-2-methylbenzamido)benzoic acid, 95.0%, 5g

Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 100mg

(5-Phenyl-1,2,4-oxadiazol-3-yl)methanol, 95%, 5g

Methyl 2-Amino-5-iodobenzoate>98.0%(GC)5g

L-4-FLUOROTRYPTOPHAN, 95.0%, 250mg

Dowtherm A, 26.5%, 1g

2-Phenylphenol Sodium Salt Tetrahydrate>98.0%(HPLC)500g